We are live on !
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
Turnover
52.78%
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter Est. Return
+15.78%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$77.6M
(+77%)
Cap. Flow
-$471K
Cap. Flow % of AUM
Cap. Flow %
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
77.6%
Holding
252
New
61
Increased
18
Reduced
33
Closed
72
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.6
years
Top 20 Avg Time Held
Equity + Options
0.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.8
years
Top 20 Avg Time Held Equity only
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.81M |
| 2 |
Amazon
AMZN
|
+$1.57M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$1.48M |
| 4 |
Franklin Templeton
BEN
|
+$936K |
| 5 |
Silicon Motion
SIMO
|
+$913K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$863K |
| 2 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$822K |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$792K |
| 4 |
Sarepta Therapeutics
SRPT
|
+$778K |
| 5 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$653K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.75% |
| 2 | Financials | 33.86% |
| 3 | Healthcare | 7.1% |
| 4 | Technology | 4% |
| 5 | Consumer Discretionary | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bank of America
BAC
$353B
| $55.1M | 30.93% |
2,491,048
| – | – |
2013 Q2
14 quarters
|
|
|
2
Amazon
AMZN
$2.83T
| $3M | 1.69% |
80,040
+40,000
| +100% | +$1.57M |
2015 Q2
6 quarters
|
|
3
Bristol-Myers Squibb
BMY
$121B
| $2.78M | 1.56% |
47,500
| – | – |
2015 Q3
5 quarters
|
|
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $2.24M | 1.26% |
+10,000
| New | +$2.18M |
2016 Q4
0 quarters
|
|
|
5
Salesforce
CRM
$199B
| $1.71M | 0.96% |
+25,000
| New | +$1.81M |
2016 Q4
0 quarters
|
|
|
ARIA
6
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.44M | 0.81% |
115,900
+5,000
| +5% | +$60.2K |
2013 Q4
12 quarters
|
|
7
Tootsie Roll Industries
TR
$2.81B
| $1.43M | 0.81% |
48,472
| – | – |
2014 Q4
8 quarters
|
|
|
ACBI
8
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.24M | 0.69% |
65,000
| – | – |
2015 Q4
4 quarters
|
|
|
MLNX
9
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.23M | 0.69% |
30,000
| – | – |
2014 Q2
10 quarters
|
|
10
Aclaris Therapeutics
ACRS
$496M
| $1.22M | 0.69% |
45,061
+22,561
| +100% | +$575K |
2015 Q4
4 quarters
|
|
11
CALL
ICICI Bank
IBN
$106B
| $1.2M | 0.67% |
176,000
+66,000
| +60% | +$470K |
2016 Q3
1 quarter
|
|
12
PUT
Invesco QQQ Trust
QQQ
$486B
| $1.18M | 0.67% |
+10,000
| New | +$1.18M |
2016 Q4
0 quarters
|
|
|
13
CALL
Bank of America
BAC
$353B
| $1.1M | 0.62% |
50,000
-75,000
| -60% | -$1.44M |
2015 Q2
6 quarters
|
|
|
14
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $995K | 0.56% |
100,000
| – | – |
2013 Q2
14 quarters
|
|
|
15
Franklin Templeton
BEN
$15.6B
| $990K | 0.56% |
+25,000
| New | +$936K |
2016 Q4
0 quarters
|
|
16
Boston Scientific
BSX
$65.3B
| $976K | 0.55% |
45,110
| – | – |
2013 Q2
14 quarters
|
|
|
LTS
17
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $939K | 0.53% |
385,000
| – | – |
2013 Q2
14 quarters
|
|
|
ARIA
18
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $933K | 0.52% |
75,000
+20,000
| +36% | +$241K |
2016 Q2
2 quarters
|
|
19
Micron Technology
MU
$1.02T
| $877K | 0.49% |
40,000
-10,000
| -20% | -$188K |
2016 Q2
2 quarters
|
|
|
20
CALL
Boston Scientific
BSX
$65.3B
| $865K | 0.49% |
40,000
-50,000
| -56% | -$1.09M |
2016 Q2
2 quarters
|
|
|
21
Silicon Motion
SIMO
$7.31B
| $850K | 0.48% |
+20,000
| New | +$913K |
2016 Q4
0 quarters
|
|
|
FNM.PRS
22
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
| $840K | 0.47% |
105,000
| – | – |
2013 Q3
13 quarters
|
|
23
Alphabet (Google) Class A
GOOGL
$4.21T
| $792K | 0.45% |
+20,000
| New | +$800K |
2016 Q4
0 quarters
|
|
24
Acadia Pharmaceuticals
ACAD
$3.38B
| $750K | 0.42% |
26,000
+15,215
| +141% | +$403K |
2016 Q2
2 quarters
|
|
25
DELISTED
Cogentix Medical, Inc.
CGNT
| $747K | 0.42% |
371,547
+250
| +0.1% | +$511 |
2015 Q2
6 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q4 2016 Portfolio in Review
As of Q4 2016, E.E. Geduld held 252 positions worth $178M, up 77% from $100M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
E.E. Geduld's Q4 2016 filing shows 61 new, 18 increased, 33 reduced and 72 closed positions. Its largest new stake was Salesforce: 25,000 shares worth $1.71M. The largest sale was Broadcom, an estimated $863K.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- E.E. Geduld's largest Q4 2016 buy was Salesforce: 25,000 shares worth $1.71M.
- E.E. Geduld added most to Amazon in Q4 2016, an estimated $1.57M increase.
- E.E. Geduld's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $778K.
- E.E. Geduld fully exited Broadcom in Q4 2016, selling an estimated $863K.
- E.E. Geduld's ten largest holdings make up 78% of its $178M portfolio in Q4 2016.
- E.E. Geduld opened 61 new positions and closed 72 in Q4 2016.
- E.E. Geduld's portfolio value rose 77% quarter-over-quarter to $178M.
Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.